Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer

The aim of this study was to assess homologous recombination deficiency (HRD) status and its correlation with carboplatin treatment response in early triple-negative breast cancer (TNBC) patients.